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ABSTRACT
Toxin-antitoxin (TA) systems play key roles in bac-
terial persistence, biofilm formation and stress re-
sponses. The MazF toxin from the Escherichia coli
mazEF TA system is a sequence- and single-strand-
specific endoribonuclease, and many studies have
led to the proposal that MazF family members ex-
clusively target mRNA. However, recent data indi-
cate some MazF toxins can cleave specific sites
within rRNA in concert with mRNA. In this report,
we identified the repertoire of RNAs cleaved by
Mycobacterium tuberculosis toxin MazF-mt9 using
an RNA-seq-based approach. This analysis revealed
that two tRNAs were the principal targets of MazF-
mt9, and each was cleaved at a single site in ei-
ther the tRNAPro14 D-loop or within the tRNALys43 an-
ticodon. This highly selective target discrimination
occurs through recognition of not only sequence but
also structural determinants. Thus, MazF-mt9 repre-
sents the only MazF family member known to tar-
get tRNA and to require RNA structure for recog-
nition and cleavage. Interestingly, the tRNase activ-
ity of MazF-mt9 mirrors basic features of eukary-
otic tRNases that also generate stable tRNA-derived
fragments that can inhibit translation in response to
stress. Our data also suggest a role for tRNA distinct
from its canonical adapter function in translation, as
cleavage of tRNAs by MazF-mt9 downregulates bac-
terial growth.
INTRODUCTION
Tuberculosis is an ancient and resilient disease caused by
Mycobacterium tuberculosis, a bacterial pathogen charac-
terized by a slow growth rate and the ability to cause a long-
term asymptomatic infection, known as latent tuberculosis
infection (LTBI), in which the bacteria are thought to per-
sist in a dormant state. The molecular events that underlie
entry into and exit from this persistent state remain unclear.
However, toxin-antitoxin (TA) systems have been suggested
to play a role in LTBI because toxins can regulate growth
and in Escherichia coli can induce a ‘quasi-dormant’ state
(1) bearing a striking resemblance to the nonreplicating per-
sistent state of M. tuberculosis. TA systems also play key
roles in biofilm formation and stress responses (2–4), both
of which are critical for M. tuberculosis pathogenesis. Cu-
riously, the M. tuberculosis genome harbors an unusually
high number of potential TA systems (>80), considerably
more than any other pathogen (5,6). Several of these TA
transcripts or proteins inM. tuberculosis are either induced
or downregulated under stresses that the pathogen might
encounter during infection, such as hypoxia (6–8), DNA
damage (9), nutrient limitation (8,10,11), macrophage in-
fection (6,12–14), heat shock (15) and treatment with an-
tibiotics (8,16–18). Collectively, these observations are con-
sistent with a role for TA systems inM. tuberculosis persis-
tence, dormancy and stress responses (19–22).
Thewell-studiedE. coli mazEFTA system serves as a use-
ful foundation to examine the role of TA systems inM. tu-
berculosis. This bicistronic operon encodes the intracellular
toxinMazF and its inhibitor, antitoxinMazE. The two pro-
teins interact to form a stable complex in which the toxin is
neutralized in the absence of stress (23). However, cellular
proteases degrade MazE upon certain stresses (23,24) and
release MazF. This MazF toxin is an endoribonuclease that
cleaves single-stranded ACA sequences to inhibit transla-
tion and bacterial growth (25,26). However, sustained toxin
expression can lead to cell death (27–29). Unlike endori-
bonuclease toxins in the RelE family, MazF toxins do not
require association with ribosomes for RNA cleavage activ-
ity (25).
The M. tuberculosis genome harbors nine TA systems
that are members of the mazEF family, whereas most
prokaryotes only have one or two (5,6). Although the roles
of so many seemingly redundant genes are still unknown,
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each M. tuberculosis MazF toxin (MazF-mt1 through
MazF-mt9) appears to recognize and cleave a unique RNA
sequence. Using primer extension studies, MazF-mt1 (lo-
cus Rv2801c) was reported to specifically recognize and
cleave U↓AC sequences of RNA (30), where ‘↓’ indicates
the exact location of cleavage. Using the same method,
MazF-mt7 (Rv1495) was reported to cleave U↓CGCU se-
quences (31), and MazF-mt6 (Rv1102c) was reported to
cleave at UU↓CCU sequences (32,33). In prior work, we
developed an RNA-seq approach termed MORE RNA-
seq (mapping by overexpression of an RNase in E. coli)
to identify the sequence specificities of endoribonuclease
toxins (34). Using this method, we determined that MazF-
mt3 (Rv1991c) actually recognizes U↓CCUU (34), not
UU↓CCU or CU↓CCU as originally reported by primer
extension (31). Although MazF orthologs were originally
proposed to exclusively target mRNA (25,26,30,31,35,36),
we and others have demonstrated that at least three MazF
toxins––E. coliMazF,MazF-mt3 andMazF-mt6––also tar-
get 23S or 16S rRNA at specific sites (32–34,37).
Because the conditions that activate MazF toxins in M.
tuberculosis are unknown and since the characterizedMazF
family members in M. tuberculosis each cleave a unique
RNA sequence and have the potential to target mRNA
or rRNA, each MazF in this pathogen may have a dis-
tinct physiological trigger, effect and role. In fact, individual
MazF toxins from M. tuberculosis are induced either dur-
ing nutrient starvation (8,10,11), upon overexpression of a
cell cycle regulation protein (38), during hypoxia or antibi-
otic treatment (8) or during conversion to a ‘non-culturable’
state (39). In addition, expression of a MazF toxin fromM.
tuberculosis increases the level of persisters (40), simulta-
neous deletion of three mazF genes impairs formation of
M. tuberculosis persister cells (8) and expression or dele-
tion of individual mazF genes alters persister recovery in
a drug-specific manner in M. tuberculosis (18). Finally, a
triple mazF deletion strain of M. tuberculosis hinders my-
cobacterial growth in guinea pigs and elicits reduced pathol-
ogy in the lungs and liver relative to the wild-type strain,
suggesting some MazF toxins may work together as viru-
lence factors (8).
To better understand the physiological role of the nine
M. tuberculosis mazEF TA systems, we characterized the
features of the MazF-mt9 toxin (locus Rv2063A) by em-
ploying our specialized RNA-seq approach to pinpoint its
RNA targets. Our biochemically validated RNA-seq results
demonstrate that recognition of tRNA and the targeted se-
lection of only a few tRNAs from among the 45 total in
M. tuberculosis occurs in a manner that is unprecedented
for aMazF toxin because it involves recognition of both se-
quence and structural determinants. Thus, all MazF toxins
do not primarily target mRNAs, and protein sequence and
structure alone does not always predict precise functional
relationships between members within toxin families.
MATERIALS AND METHODS
Strains, plasmids and reagents
The E. coli strains BW251136 [lacIq rrnBT14 lac-ZWJ16
hsdR514 araBADAH33 rhaBADLD78 chpBIK dinJ-
yafQ hipBA mazEF relBE yefM-yoeB] (41) and
BL21(DE3) [F− ompT hsdS(r−, m−) dcm gal (DE3);
Novagen] were used for all RNA cleavage and pro-
tein expression studies, respectively. E. coli Mach1-T1
[F− recA1398 endA1 tonA 80(lacZ)M15 lacX74
hsdR(r−, m+); Invitrogen] cells were used for all cloning
experiments. M. tuberculosis strain H37Rv (ATCC) was
used for all growth and toxicity experiments. Plasmids
used were pET-21c and pET-28a (Novagen), pBAD33 (42),
pColdTF-FT (43) and pMC1s (ATCC). The mazF-mt9
(Rv2063A locus) and mazE-mt9 (Rv2063 locus) genes were
PCR-amplified fromM. tuberculosis strain H37Rv genomic
DNA with 5′-NdeI/BamHI-3′ ends to create pET-21c-
mazF-mt9 and pET-28a-mazE-mt9, respectively. To create
pBAD33-mazF-mt9, the pET-21c-mazF-mt9 plasmid was
digested with XbaI and HindIII to include the highly ef-
ficient T7 phage ribosome binding site, and the resulting
fragment was cloned into pBAD33. To create pColdTF-FT-
mazF-mt9 and pMC1s-mazF-mt9, pET-21c-mazF-mt9 was
digested with NdeI and BamHI, and the resulting fragment
was cloned into pColdTF-FT and pMC1s, respectively. To
generate sequencing ladders for primer extension analysis
in E. coli, the entire ompF transcript or the lpp and ompA
CDSs were PCR-amplified from E. coli strain BW251136
cultures and ligated into Strataclone PCR cloning vectors
(Agilent) to create pSC-A-ompF, pSC-A-lpp or pSC-A-
ompA, respectively.M. tuberculosis tRNA genes were PCR-
amplified as described in more detail later and ligated into a
Strataclone PCRcloning vector to create pSC-A-tRNAPro14
or pSC-A-tRNALys43. Clones were confirmed by DNA se-
quence analysis. All E. coli cells were grown at 37◦C in M9
minimal medium supplemented with a final concentration
of either 0.2% glucose or 0.1% glycerol. All M. tubercu-
losis cells were grown in 7H9 Middlebrook medium sup-
plemented with a final concentration of 0.05% Tween 80,
0.5%bovine albumin, 0.2% glucose and 0.085%NaCl (7H9-
TW80-ADN). The working concentrations of ampicillin
and chloramphenicol in E. coli were 100 and 25 g/ml, re-
spectively, while the final concentration of kanamycin inM.
tuberculosis was 20 g/ml.
Growth and toxicity assays
MazF-mt9was expressed inE. coli strain BW251136 from
an arabinose-inducible promoter in pBAD33-mazF-mt9 us-
ing a final concentration of 0.2% arabinose and in M. tu-
berculosis strain H37Rv from a tetracycline-inducible pro-
moter in pMC1s-mazF-mt9 using a final concentration of
200 ng/ml anhydrotetracycline (ATC). For assessing tox-
icity of MazF-mt9 expression, E. coli transformants har-
boring either pBAD33 or pBAD33-mazF-mt9 were plated
on solid M9 medium with 0.1% glycerol and either with or
without a final concentration of 0.2% arabinose and were
incubated overnight at 37◦C. For growth profiles, E. coli
transformants harboring pBAD33-mazF-mt9 were grown
overnight at 37◦C in M9 liquid medium with 0.2% glucose
and diluted to an OD600nm of ≈0.15 in M9 liquid medium
with 0.1% glycerol. Cultures were grown at 37◦C to an
OD600nm of 0.28 (1.5 h post-dilution), the cultures were split
into two flasks and arabinose was added to one culture to
a final concentration of 0.2% to induce MazF-mt9. For as-
sessing toxicity of MazF-mt9 expression inM. tuberculosis,
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transformants harboring either pMC1s or pMC1s-mazF-
mt9 were serially diluted, plated on solid 7H9-TW80-ADN
medium supplemented with or without a final concentra-
tion of 200 ng/ml ATC, and incubated overnight at 37◦C.
For growth profiles in M. tuberculosis, transformants har-
boring either pMC1s or pMC1s-mazF-mt9 were grown in
7H9-TW80-ADN liquid medium at 37◦C with a final con-
centration of 200 ng/ml ATC to induce MazF-mt9 expres-
sion. ATC was added every 48 h, and spent culture super-
natant was used as specified in Sharp et al. (44).
Assessment of protein synthesis in vivo
E. coli BW251136 cells harboring pBAD33-mazF-mt9
were grown in M9 minimal medium with a final concentra-
tion of 0.1% glycerol and 1 mM of all amino acids except
Cys and Met at 37◦C until reaching an OD600nm between
0.2 and 0.3. The culture was then split into equal portions.
Arabinose was added to one portion at a final concentra-
tion of 0.2%. Aliquots were removed at the indicated times
and incubated with 30 Ci of [35S]Met at 37◦C. After 1 min
of incorporation, the samples were chased with 0.3 mg of
cold methionine at 37◦C for 5 min. A portion of the culture
was applied to a cellulose filter disc (Whatman). The filters
were boiled for 30 min in 10% trichloroacetic acid (TCA)
and washed three times with 10% TCA and once with ace-
tone. The amount of incorporated radioactivity was deter-
mined using a liquid scintillation counter. Cells from each
time point were centrifuged, and pellets were resuspended in
equivalent volumes of Tris-EDTA buffer (pH 8.0) and 2×
Laemmli buffer corresponding to the measured OD600nm.
Incorporation was visualized by autoradiography following
17.5% SDS-PAGE.
RNA isolation
Total RNA was isolated from E. coli strain BW251136
harboring either pBAD33 or pBAD33-mazF-mt9 orM. tu-
berculosis strain H37Rv grown to mid-logarithmic phase.
When E. coli cultures reached an OD600nm of 0.4, the cul-
tures were split into two flasks, arabinose was added to one
culture to a final concentration of 0.2%, and growth con-
tinued for an additional 15-, 30-, 60-, 90- or 120-min post-
induction. Cells were pelleted by centrifugation at 2000 × g
for 10 min, and supernatants were removed. E. coli cell pel-
lets were resuspended in acid phenol and lysed for 10 min at
60◦C. Lysates were extracted with chloroform and precipi-
tated with ethanol. RNA pellets were dissolved in nuclease-
free water, treated with TURBO DNase (Invitrogen) for 45
min at 37◦C, extracted with acid phenol chloroform and
precipitated with ethanol. M. tuberculosis cell pellets were
resuspended in TRIzol Reagent (Invitrogen) and lysed by
bead-beating. Lysates were extracted with chloroform and
precipitated with isopropanol. RNA pellets were dissolved
in nuclease-free water and treated with TURBODNase (In-
vitrogen) for 60 min at 37◦C.
Northern analysis of steady-state mRNA and tRNA levels
To detect mRNA, 25 g of total RNA from E. coli
was loaded onto a 1.2% (wt/vol) agarose, 2% (vol/vol)
formaldehyde gel and visualized by adding ethidium bro-
mide and exposing to UV light. To detect tRNA, 2 g
of total RNA from E. coli was separated on a 9% poly-
acrylamide, 7 M urea gel and visualized by SYBR Gold
(Invitrogen) staining. RNA was transferred to a nylon
Hybond-N+ membrane (GE Healthcare) and hybridized
with radiolabeled DNA overnight at 42◦C. To detect E. coli
tRNALys, a DNA oligonucleotide specific for that tRNA
species (NWO2358, 5′- AGTCAACTGCTCTACCAACT-
GAGC -3′) was radiolabeled at the 5′ end by treating with
T4 polynucleotide kinase (New England Biolabs) and [ -
32P]ATP (PerkinElmer) for 1 h at 37◦C. To detect mRNA,
the radiolabeled DNA for northern analysis was generated
with a random-primed DNA labeling kit (Roche) using
PCR products amplified from the CDSs of E. coli genes
lpp, ompA, ompC, ompF, ompX, rplB, rpsA and tsf, or from
a portion of two transcripts containing tufA. E. coli con-
tains two genes, tufA and tufB, that encode elongation fac-
tor EF-Tu and whose nucleotide sequences are 99% identi-
cal. To detect tufA but not tufB transcripts, a tufA-specific
fragment was created using primers that overlap a portion
of the upstream gene fusA and end just before the start of
the tufA CDS. This fragment hybridizes to four mRNAs,
including a transcript containing fusA and tufA, two tran-
scripts of roughly equal size containing only tufA, and one
containing rpsL, rpsG, fusA and tufA.
In vivo primer extension analysis
Total RNA (25 g) from E. coli expressing MazF-mt9
was used in primer extension reactions, and sequencing
ladders were generated by using 5 g of plasmids carrying
E. coli genes (pSC-A-lpp, pSC-A-ompA or pSC-A-ompF),
[-32P]dCTP for radiolabeling and a Sequenase version 2.0
DNA sequencing kit (Affymetrix) according to the Seque-
nase kit protocol, essentially as described in Sharp et al.
(44) and Schifano et al. (34). DNA oligonucleotides were
radiolabeled at the 5′ end by treatingwith T4 polynucleotide
kinase and [ -32P]ATP for 1 h at 37◦C. The oligonucleotide
NWO1171 (5′-TTACTTGCGGTATTTAGTAGCC-3′)
was used to detect cleavage in the lpp CDS, the primer
NWO1582 (5′-CACTGGTATTCCAGACGGG-3′) was
used for the ompA CDS, and primer NWO1614 (5′-
CGCTTCATCATTATTTATTACCCTCATGG-3′) was
used for the ompF 5′ UTR. Cleavage products were detected
by extending 1.4 pmol of gene-specific 5′-end-radiolabeled
oligonucleotides with 5 U of avian myeloblastosis virus
reverse transcriptase (AMV RT; New England Biolabs)
and 20 U of RNase inhibitor (Roche) for 1 h at 42◦C. All
reactions were electrophoresed on a 6% (wt/vol) polyacry-
lamide 7 M urea gel and visualized by autoradiography.
Preparation of recombinant MazE-mt9 and MazF-mt9
pET-28a-mazE-mt9 or pColdTF-FT-mazF-mt9
BL21(DE3) transformants were used to inoculate one
or four liters of M9 liquid medium and grown to an
OD600nm of 0.50 or 0.35, respectively. For pET-28a-mazE-
mt9 BL21(DE3) transformants, cultures were induced with
a final concentration of 1 mM IPTG and expressed at
37◦C for 4 h. For pColdTF-FT-mazF-mt9, the method of
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purifying a toxin protein was similar to our group’s pub-
lished work (32,43). Cultures were transferred to a 15◦C
water bath and incubated for 30 min before the protein
was induced with a final concentration of 1 mM IPTG and
expressed for 20 h. Cells were disrupted by sonication, and
extracts were purified by nickel-nitrilotriacetic acid affinity
chromatography (Qiagen). To produce sufficient amounts
of toxic protein, MazF-mt9 was expressed as a fusion
to the 55-kDa molecular chaperone trigger factor (TF).
Presumably the relatively large size of the chaperone fusion
precludes the cytotoxic effects of overexpressing a toxin in
culture. We suspect that TF either blocks dimerization of
toxin monomers, precludes proper folding of the toxin or
inhibits interaction between the toxin and its RNA target.
After cell lysis, His6-TF-FLAG-MazF-mt9 was cleaved
with Factor Xa (New England Biolabs) to excise TF from
the target protein. FLAG-MazF-mt9 was further purified
over an anti-FLAG resin to removeHis6-TF, which resulted
in approximately 8 nmol of protein. Purity of the toxin was
confirmed by SDS-PAGE analysis and silver staining.
In vitro primer extension analysis of MS2 RNA
Cleavage products were detected and DNA se-
quencing ladders were generated using the fol-







3′. Oligonucleotides were radiolabeled as above. For primer
extension, RNA cleavage and antitoxin rescue was per-
formed with or without a final concentration of 5.0 M
MazF-mt9 or 10.0 M MazE-mt9 in 10 mM Tris (pH
7.8). For antitoxin inhibition of RNA cleavage, 50 pmol
MazF-mt9 was pre-incubated with 100 pmol MazE-mt9
for 20 min at 4◦C and 5 min at room temperature before
the RNA substrate was added. Cleavage reactions using 0.8
g (0.77 pmol) of MS2 RNA (Roche) as a substrate were
incubated with or without 50 pmol ofMazF-mt9 for 45 min
at 37◦C. Primer extension reactions were then performed at
50◦C for 1 h with 1 pmol of 5′-end-radiolabeled primer, 10
U of RNase inhibitor and 2.5 U AMV RT in the supplied
enzyme buffer. For DNA sequencing reactions, 1 pmol of
5′-end-radiolabeled primer was annealed to 0.8 g (0.77
pmol) of MS2 RNA for 30 s at 80◦C and allowed to cool
to room temperature. The sequencing reactions were then
performed at 50◦C for 1 h using 10 U of RNase inhibitor
and 1 U of AMV RT, as well as dNTPs and ddNTPs
from the Sequenase version 2.0 DNA sequencing kit at the
concentration recommended by the manufacturer. Samples
were electrophoresed and visualized as above.
Identification of MazF-mt9 cleavage sites by RNA-seq
Preparation of RNA for high-throughput sequencing. The
procedure to prepare RNA for high-throughput sequenc-
ing was essentially as described in Schifano et al. (34),
with the major alteration of only isolating RNA with a
5′-OH end and the inclusion of an additional set per-
formed with M. tuberculosis RNA incubated with MazF-
mt9 toxin in vitro. Total RNA was harvested from either E.
coli cells harboring a pBAD33 plasmid withoutMazF-mt9,
E. coli cells expressing MazF-mt9 from pBAD33-mazF-
mt9 or plasmid-free M. tuberculosis cells. For in vivo ex-
periments, total RNAwas harvested 90-min post-induction
from two E. coli biological replicates to coincide with the
start of growth arrest in MazF-mt9-expressing cells (Fig-
ure 1B). RNA from each of these biological replicates was
also split into two technical replicates, one treated with
a MICROBExpress kit (Ambion) to deplete rRNAs and
one in which rRNAs were not depleted. For in vitro ex-
periments, 4.48 g of M. tuberculosis total RNA was in-
cubated with or without 692 pmol of recombinant MazF-
mt9 protein for 45 min at 37◦C in a final concentration of
10 mM Tris (pH 7.8), and rRNAs were not depleted. With
a goal of retaining RNA cleavage fragments <200 nt, to-
tal RNA was not passed through an RNeasy Mini Kit (Qi-
agen). To isolate RNAs with a 5′-OH, 3.25 g of E. coli
RNA or 3.90 g of M. tuberculosis RNA was treated with
1 U of Terminator 5′-Phosphate-Dependent Exonuclease
(Epicentre) to remove RNAs with a 5′-monophosphate (5′-
P), followed by phosphorylation by 50 U of OptiKinase
(Affymetrix) to convert 5′-OH to 5′-P suitable for ligation.
The resultant RNAs were then ligated to the 5′ SOLiD
(Sequencing by Oligonucleotide Ligation and Detection)
RNA adaptor (5′-CCACUACGCCUCCGCUUUCCUC
UCUAUGGGCAGUCGGUGAU-3′). Ligation reactions
contained 5′-P RNA, 75 pmol 5′ SOLiD adaptor and 20 U
T4 RNA Ligase I (New England Biolabs). Ligations were
incubated for 20 h at 16◦C. Ligation reactions were elec-
trophoresed on a 6% (wt/vol) polyacrylamide 7 M urea gel
in TBE buffer, and RNAs that migrated above the free 5′
adaptor were isolated by gel excision. After ligation, cD-
NAs were generated by reverse transcription using a primer
that contained nine degenerate nucleotides at the 3′ end and
a common ‘3’ SOLiD adaptor’ sequence (5′-CTGCTGTA
CGGCCAAGGCGNNNNNNNNN-3′). ForE. coliRNA,
the annealing step was performed by mixing 350 to 600 ng
of 5′ adaptor-ligated RNA with 60 pmol of the RT primer,
while forM. tuberculosisRNA, 250 to 360 ng of 5′ adaptor-
ligated RNA was mixed with 50 pmol of the RT primer.
These mixtures were annealed by incubating for 3 min at
85◦C to allow unfolding of secondary structures in rRNA
and tRNA followed by 5 min at 4◦C. Reverse transcrip-
tion was performed by adding a cocktail containing 300
U SuperScript III reverse transcriptase (Invitrogen), reac-
tion buffer, dNTPs and RNase inhibitor to the RT primer-
RNAmixture and incubating for 5min at 25◦C, then 60min
at 55◦C. The reverse transcriptase was then inactivated by
incubating for 15 min at 70◦C. Next, to remove the RNA
strand from RNA-DNA hybrids, 20 U of RNase H (Am-
bion) was added, and reactions were incubated for 20 min
at 37◦C. Samples were electrophoresed on a 10% (wt/vol)
polyacrylamide 7 M urea gel, and cDNAs that migrated
between ≈125 nt and ≈500 nt were isolated by gel exci-
sion. PCR of cDNA was performed with an initial denat-
uration step of 30 s at 98◦C, amplification for 11–14 cy-
cles (denaturation for 10 s at 98◦C, annealing for 20 s at
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62◦C and extension for 10 s at 72◦C) and a final exten-
sion for 7 min at 72◦C using reagents from a SOLiD to-
tal RNA-seq kit and primers from a SOLiD RNA bar-
coding kit (Applied Biosystems). After electrophoresis on a
non-denaturing 10% (wt/vol) polyacrylamide gel, amplified
DNA that migrated between the 200 bp and 400 bp DNA
standards was isolated by gel excision and sequenced using
an Applied Biosystems SOLiD system, version 4.0.
RNA-seq data analysis. We obtained between 4 and 10
million sequencing reads that aligned to theE. coliMG1655
genome (Supplementary Table S1) and between 6 and 7mil-
lion sequencing reads that aligned to the M. tuberculosis
strain H37Rv genome (Supplementary Table S2). Sequenc-
ing reads for which the first 15 or 20 bases mapped with
zero mismatches to the E. coli or M. tuberculosis genomes,
respectively, were identified using Bowtie version 1.0.0 (45).
The number of sequencing reads whose first base aligned to
each position in the genome (#5′-ends) was calculated. For
E. coli libraries, replicates were averaged. Next, we added
a pseudocount to the genomic positions for which the #5′-
ends was zero. We then divided the #5′-ends from the anal-
ysis of RNA isolated from cells containing MazF-mt9 with
the #5′-ends from cells that did not contain MazF-mt9. We
identified genomic positions for which this ratio was ≥50
either in the analysis of both biological replicates in E. coli
or in the single M. tuberculosis cDNA library. In addition,
we required that the position of enrichment represented lo-
cal maxima within a 30-base window spanning 15 bases up-
and downstream. In the analysis of E. coli RNAs carrying
a 5′-OH, we identified 163 positions that met these crite-
ria, while in the analysis ofM. tuberculosis RNAs carrying
a 5′-OH, we identified 48 positions that met these criteria
(Supplementary Data 1). For cleavage sites that mapped to
more than one position in the E. coli genome due to redun-
dant sequences, the sequence surrounding each cleavage site
was only counted once to determine the consensus sequence
in Figure 2E. Values for fold-change in Figure 2A, C and
F were calculated from the average of the two biological
replicates whose rRNAs were not depleted. The RNA se-
quencing data were deposited in the NCBI Sequence Read
Archive under accession code PRJNA289381.
In vitro synthesis of tRNA
M. tuberculosis tRNAs were synthesized in vitro fol-
lowing the methods described by Sisido et al. (46)
with minor modifications. A synthetic DNA oligonu-
cleotide containing the T7 RNA polymerase promoter
and the 5′-end of the tRNA gene was annealed to a
second oligonucleotide corresponding to the 3′-end of
the tRNA. The following oligonucleotide primers were
used (T7 RNA polymerase promoter is underlined):
tRNAPro14 gene proT forward (Fwd), NWO2098, 5′-
GCAGCGAAATTAATACGACTCACTATAGCGGG
CTGTGGCGCAGTTTGGTAGCGCACTTGACT-3′;
tRNAPro14 gene proT reverse (Rev), NWO2143, 5′-
TCGGGCTGACAGGATTTGAACCTGCGACCACT
TGACCCCCAGTCAAGTGCGCTACCAAACTGCG-
3′; tRNALys43 gene lysT Fwd, NWO2078, 5′-
GCAGCGAAATTAATACGACTCACTATAGGC
CCCTATAGCTCAGTTGGTAGAGCTACGGAC-3′;
tRNALys43 gene lysT Rev, NWO2079, 5′-TTGTGCCCCC
ACCAGGACTCGAACCTGGGACCTGCGGATTAA
AAGTCCGTAGCTCTACCAACTGAGCTATAGGG-
3′. The annealed oligonucleotides were then extended
using Taq DNA polymerase to create dsDNA containing
the entire tRNA gene preceded by the T7 promoter. The
product was electrophoresed on a 2% (wt/vol) agarose gel
to confirm its size and purified using the QIAquick gel
extraction kit (Qiagen). The sequence of the product was
confirmed by DNA sequence analysis. 200 ng of tRNA
gene dsDNA was then transcribed in vitro for 4 to 6 h at
37◦C using the RiboMAX Large Scale RNA Production
System (Promega) as recommended by the manufacturer.
The transcription reaction was then electrophoresed on a
9% (wt/vol) polyacrylamide 7 M urea gel and visualized
by staining with ethidium bromide to confirm the size and
purity of the transcribed tRNA. The tRNA transcript was
excised from the gel and incubated for 18 h at 37◦C in
elution buffer (1 mM EDTA, 0.5 M ammonium acetate,
10 mM magnesium acetate, 0.1% SDS). The eluate was
collected, and the tRNA was precipitated by ethanol.
In vitro primer extension analysis of tRNAs
Cleavage of tRNAs produced via T7 transcription was per-
formed in vitro following the assay described by Winther
and Gerdes (47) with slight modifications. Cleavage reac-
tions using 3 pmol of tRNA were incubated with 30 pmol
of MazF-mt9 at 37◦C for 5.5 h in tRNA cleavage buffer
(10 mM HEPES (pH 7.5), 15 mM potassium chloride, 3
mM magnesium chloride and 10% glycerol). For antitoxin
inhibition of RNA cleavage, 30 pmol MazF-mt9 was pre-
incubated with 20 pmol MazE-mt9 for 15 min at room
temperature before the RNA substrate was added. Cleav-
age products were detected and DNA sequencing ladders
were generated using the following oligonucleotide primers:
tRNAPro14 gene proT, NWO2144, 5′-TCGGGCTGACAG
GATTTGAACC-3′; tRNALys43 gene lysT NWO2080, 5′-
TTGTGCCCCCACCAGGAC-3′. Oligonucleotides were
radiolabeled exactly as above, while primer extension re-
actions were the same as in the ‘In vitro primer extension
analysis of MS2 RNA’ section except they were incubated
at 55◦C. DNA sequencing reactions using 3.5 g plasmid
DNA (pSC-A-tRNAPro14 or pSC-A-tRNALys43) as a tem-
plate and [-32P]dATP for radiolabeling were performed
with a Sequenase version 2.0DNA sequencing kit as recom-
mended by the manufacturer. The samples were incubated
at 95◦C for 5 min prior to electrophoresis on a 15% (wt/vol)
polyacrylamide, 7 M urea gel followed by autoradiography.
Statistical analysis of proline, lysine and asparagine codon
frequency inM. tuberculosis CDS
TheM. tuberculosis strain H37Rv genome (accession num-
ber NC 000962) was retrieved from NCBI RefSeq, and all
pseudogenes were removed. The counts of each of the 64
possible codons in all CDSs were tallied. These individ-
ual counts were divided by the sum of all counts to obtain
the probability of each codon appearing in any M. tuber-
culosis CDS. We defined tRNAPro14-recognized codons as
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CCC, the perfect reverse complement of the tRNAPro14 an-
ticodon, and CCU, an ‘orphan’ proline codon inM. tuber-
culosis that does not have a natural anticodon match but
can be recognized by tRNAPro14 due to wobble base-pair
rules (48). Thus, the probabilities of proline (CCC, CCU),
lysine (AAA, AAG) and asparagine (AAC, AAU) codons
appearing anywhere in anM. tuberculosisCDS are 0.02047,
0.02041 and 0.02532, respectively. Let p denote their com-
bined probability of 0.0662. Let L be 30 to indicate the first
30 codons in the CDS. The expected number, E, of the de-
scribed codons among the first 30 codons is:
E = pL
Let K be the actual number of these three sets of codons.
Then the probability,P, of havingK ormore of these codons
among the first L codons of the CDS is:
P = 1 −
K−1∑
i=0
pi (1 − p)L−i L!
i !(L− i )!
To calculate the P-value for the entire CDS from a given
mRNA, the value for L is replaced with the number of
codons in the CDS. A CDS with a very small P-value sug-
gests that its translation may be sensitive to MazF-mt9
cleavage of tRNAPro14, tRNALys and tRNAAsn isoforms.
In vitro cleavage of tRNALys43 and several short RNAs based
on the tRNALys43 ASL
Cleavage of tRNALys43 produced via T7 transcription and
of 15-nt RNA oligonucleotides based on the wild-type or
mutant tRNALys43 ASL was performed in vitro in a man-
ner similar to that in the tRNA primer extension analy-
sis above. We designed RNA oligonucleotides that either
match the wild-type tRNALys43 ASL or contain mutations
that disrupt RNA sequence or secondary structure as il-
lustrated in Figure 4. The RNA oligonucleotides based
on the tRNALys43 ASL are as follows, with stem-forming
bases underlined and mutated bases in bold: NWO2233,
wild-type, 5′-CGGACUUUUAAUCCG-3′, Figure 4A,
lanes 4–6, and Figure 4B, lanes 1–3; NWO2234, ‘-UUU,’
5′-CGGACUAAAAAUCCG-3′, Figure 4A, lanes 7–9;
NWO2238, ‘shifted UUU,’ 5′-CGGACUAAUUUUCCG-
3′, Figure 4A, lanes 10–12; NWO2235, ‘-stem, 5’ side,’
5′-GCCUCUUUUAAUCCG-3′, Figure 4A, lanes 13–15;
NWO2236, ‘-stem, -UUU,’ 5′-GCCUCUAAAAAUCCG-
3′, Figure 4A, lanes 16–18; NWO2237, ‘restore stem,’ 5′-
GCCUCUUUUAAAGGC-3′, Figure 4B, lanes 4–6; and
NWO2387, ‘-stem, 3′ side,’ 5′-CGGACUUUUAAAUAU-
3′, Figure 4B, lanes 7–9. We used the program RNAstruc-
ture (49) to confirm the presence or absence of a stem as
desired for each RNA oligonucleotide. To radiolabel RNA
oligonucleotides, RNA was first treated with calf intestinal
alkaline phosphatase (New England Biolabs) for 60 min
at 50◦C to remove the 5′-P. Treated RNA was extracted
with 25:24:1 phenol:chloroform:isoamyl alcohol and pre-
cipitated with ethanol. For size markers, a DNA oligonu-
cleotide and two RNA oligonucleotides were radiolabeled
at the 5′ end by treating with T4 polynucleotide kinase
and [ -32P]ATP for 1 h at 37◦C. The DNA oligonucleotide
NWO1693 (5′-GGAATTCCATATGTCTACATCCACG
ACGATTAGGG-3′) is 35-nt, while the RNA oligonu-
cleotides are 10-nt (5′-AUCCGGAAUC-3′) and 5-nt (5′-
CGCCU-3′). Treated RNA was also radiolabeled at the 5′
end as with the oligonucleotides but with the following ex-
ceptions: (i) RNA was initially incubated without enzyme
for 10 min at 70◦C and immediately placed on ice, (ii) 2.5×
more T4 polynucleotide kinase was used, (iii) polyethy-
lene glycol 8000 was added to a final concentration of 5%
(wt/vol) and (iv) the labeling reaction was incubated for 1 h
at 51◦C. Cleavage reactions using 0.1 pmol of radiolabeled
RNA were incubated with 1.0 pmol of MazF-mt9 at 37◦C
for 60min in tRNA cleavage buffer. For antitoxin inhibition
of RNA cleavage, 1.0 pmol MazF-mt9 was pre-incubated
with 0.67 pmol MazE-mt9 for 45 min at room tempera-
ture before the RNA substrate was added. Radiolabeled or
non-radiolabeled samples were electrophoresed on a 15%
(wt/vol) polyacrylamide, 7 M urea gel followed by autora-
diography or staining with SYBR Gold.
Northern analysis ofM. tuberculosis tRNA cleaved in vitro
To assess MazF-mt9 cleavage activity, 2 g of M. tuber-
culosis total RNA was incubated with 30 pmol of MazF-
mt9 in a 10 l reaction containing tRNA cleavage buffer
at 37◦C for 0, 6 or 24 h. To assess for cleavage inhibition
by the cognate antitoxin and control from contaminating
ribonucleases, 20 pmol MazE-mt9 was pre-incubated with
MazF-mt9 for 15 min at room temperature before the RNA
substrate was added and incubated at 37◦C for 24 h. The
products of these reactions were separated on a 9% (wt/vol)
polyacrylamide, 7 M urea gel and visualized by SYBR
Gold staining. RNA was transferred to nitrocellulose, and
RNA was then hybridized with a radiolabeled oligonu-
cleotide specific forM. tuberculosis tRNALys43, NWO2267,
5′-GCAGTGAGCCCCATTCG-3′.
RESULTS
Expression of MazF-mt9 arrests translation and growth
Expression of the MazF-mt9 toxin leads to growth arrest
in E. coli (50) and M. smegmatis (6). To establish whether
or not the growth inhibition observed upon MazF-mt9 ex-
pression (Figure 1A and B) is the result of translation inhi-
bition, we metabolically labeled E. coli cells with [35S]Met
in the presence or absence of MazF-mt9 at intervals corre-
sponding to those in the growth profile from 0 to 180 min
(Figure 1C and D). To limit potential trans-activation of
endogenous E. coli toxins (51–53), we performed all E. coli
experiments in a BW251136 strain carrying deletions of
six TA systems––chpBIK, dinJ-yafQ, hipBA, mazEF, relBE
and yefM-yoeB (41). The results of this analysis indicated
that inhibition of translation was the underlying cause of
the growth arrest by MazF-mt9 since translation levels de-
clined significantly before growth arrest was detected. In
particular, there was no difference between the growth rate
of MazF-mt9-induced and control cultures until 60 min
post-induction (Figure 1B), yet there was a steep decline
in de novo protein synthesis between 20 and 30 min post-
induction (Figure 1C andD). In addition, we demonstrated
that MazF-mt9 expression in M. tuberculosis also led to a
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Figure 1. Expression of MazF-mt9 arrests translation and growth. (A)
E. coli BW251136 cells transformed with arabinose-inducible pBAD33
or pBAD33-mazF-mt9 were streaked onto M9 minimal medium plates
with (right, +Arab) or without 0.2% arabinose (left, -Arab) and incubated
overnight at 37◦C. (B) Growth profile with (+F9, grey diamonds) or with-
out (-F9, black squares) addition of arabinose to E. coli cells harboring
pBAD33-mazF-mt9. (C) [35S]methionine incorporation inE. coli cells with
or without MazF-mt9 expression. Equivalent amounts of cell lysate rel-
ative to OD600nm were subjected to SDS-PAGE followed by autoradiog-
raphy. Numbers indicate the time (min) after MazF-mt9 induction. Data
shown are representative of two independent experiments. (D) Quantifica-
tion of [35S]methionine incorporation relative to OD600nm in E. coli cells
with (+F9, grey diamonds) or without (-F9, black squares) MazF-mt9 ex-
pression. The initial rate was set to 100%. (E) Effect on colony formation
with (grey) or without (black) addition of anhydrotetracycline (ATC) to
M. tuberculosisH37Rv cells harboring ATC-inducible pMC1s or pMC1s-
mazF-mt9. (F) Growth profile of M. tuberculosis cells harboring pMC1s
(black squares) or pMC1s-mazF-mt9 (grey diamonds) upon addition of
ATC. (B, D, E, F) Data points are the mean of two (D), three (B, F) or
four (E) independent experiments and error bars represent the S.D.
reduction in the recovery of colony forming units and to
growth arrest (Figure 1E and F). Expression of MazF-mt9
inhibited colony formation by nearly 200-fold relative to
the uninduced control (10 versus 1914 CFU/ml; Figure 1E)
and arrested growth inM. tuberculosis for up to 12 d post-
induction (Figure 1F). Therefore, our data revealed that
MazF-mt9 expression inhibits growth in E. coli andM. tu-
berculosis, consistent with published reports in E. coli (50)
andM. smegmatis (6).
Determinants for MazF-mt9 cleavage recognition are more
complex than for other MazF toxins
To define the RNA sequence determinants for MazF-mt9
cleavage, we first used a conventional approach involving
MazF-mt9 expression in E. coli followed by a combina-
tion of northern and primer extension analyses on natu-
rally abundant mRNAs. Upon northern analysis of the lpp,
ompA and ompF transcripts, we detected a gradual decrease
Figure 2. MORE RNA-seq uncovers MazF-mt9 sequence requirements
and tRNA as a new target. (A, C, F) Histograms representing the ratio
of sequencing reads identified using MORE RNA-seq at each nt position
within the ompA (A) or ompF (C) transcripts or within tRNALys (F) in E.
coli cells that did (+F9) or did not express (-F9) MazF-mt9. The cleavage
site is labeled with an asterisk (*). (C,D) Negative nucleotide positions cor-
respond to the 5′ UTR (shaded in green), while positive values correspond
to the ompFCDS. (B, D, H) The RNA sequences surrounding the cleavage
sites (indicated by a black arrow) identified using MORE RNA-seq (A, C,
F) and validated with primer extension (Supplementary Figure S2B and
C) or northern analysis (Figure 2G), with flanking position numbers from
the corresponding E. coliCDS, 5′ UTR, or mature tRNA, respectively. (E)
Sequence logo (75) generated by aligning the RNA sequences surrounding
the 163 cleavage sites identified using MORE RNA-seq on E. coli cells ex-
pressing MazF-mt9. The numbering reflects the nt position relative to the
exact point of cleavage, indicated by the yellow arrow. (G) Northern anal-
ysis of E. coli tRNALys with expression of toxin MazF-mt9 for the times
shown (in min), relative to empty vector (EV) after adding inducer. The
red arrow indicates the position of a cleavage product. Tick marks denote
a DNAmarker and numbers indicate length in nt. (I) Secondary structure
(above) of E. coli tRNALys, showing the location of MazF-mt9 cleavage
(inset below). The acceptor stem at the 5′ end is highlighted in red, the
D-arm in orange, the anticodon arm in light green, the anticodon in dark
green, the T-arm in blue and the CCA tail at the 3′ end in purple. Yellow
arrows indicate a cleavage site. Numbering in the anticodon indicates ma-
ture tRNA nucleotide position. (B, D, H, I) Nt identical to the MazF-mt9
motif UU↓U are in red text.
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in the levels of full length RNA upon MazF-mt9 expres-
sion (Supplementary Figure S1).We then performed primer
extension on these three RNAs and detected only a sin-
gle cleavage site in each (Supplementary Figure S2). Al-
though the three cleavage sites were all flanked by uridine
nucleotides on either side (U↓U) and two of the cleavage
sites contained a UU↓U motif, there was not enough simi-
larity in the RNA sequences surrounding the cleavage sites
to determine a definitive consensus sequence. Therefore, we
next surveyed six additional mRNAs––ompC, ompX, rplB,
rpsA, tsf and tufA––by northern analysis but were unable
to detect any evidence of MazF-mt9 cleavage (Supplemen-
tary Figure S3). Finally, we incubated the ≈3.5-kb bacte-
riophage MS2 RNA with or without purified MazF-mt9
toxin and performed primer extension analysis to obtain
more MazF-mt9 cleavage sites (Supplementary Figure S4).
In total, we identified 11MazF-mt9 cleavage sites, including
five ‘major’ sites that exhibited robust cleavage and six ‘mi-
nor’ sites with relatively weak signals (Supplementary Table
S3). Alignment of the RNA sequences flanking the MazF-
mt9 cleavage sites only revealed a U↓U sequence in com-
mon between these 11 sites (Supplementary Table S3). This
2-nt UU sequence is predicted to occur once every 42 or 16
nucleotides, or≈1,400 times collectively in the 10 RNAs we
tested, assuming an equal base content, equal representa-
tion of all potential cleavage motifs and no secondary struc-
ture. Because we observed cleavage at <1% of the UU se-
quences, MazF-mt9 appeared to require more than a UU
motif for substrate recognition and cleavage.
MORE RNA-seq uncovers MazF-mt9 sequence require-
ments and tRNA as a new target
To further define the sequence determinants for MazF-mt9
cleavage, we used MORE RNA-seq (34) to survey the tran-
scriptome of E. coli. MORERNA-seq is designed to isolate
a single class of RNA depending on the nature of the chem-
ical moiety (a monophosphate or a hydroxyl group) at the
5′ end of a transcript. Since cleavage by MazF toxins pro-
duces an RNA fragment with a 5′-hydroxyl (5′-OH) group
(25,34,36,54,55),MORERNA-seq enables identification of
cleavage sites by isolating RNA with a 5′-OH and search-
ing for genomic positions enriched when the MazF toxin is
induced compared to when the toxin is absent. Having pre-
viously demonstrated that MORE RNA-seq readily deter-
mines a cleavage recognition sequence and precisely maps
the position of cleavage (34), we applied this approach to
MazF-mt9. To this end, we harvested total RNA from E.
coli cells harboring either a vector that directs the synthesis
of MazF-mt9 or an empty plasmid, selected for transcripts
bearing a 5’-OH, prepared cDNA for high-throughput se-
quencing, and identified 163 unique cleavage sites. As val-
idation of our MORE-RNA-seq approach, two of the 163
sites––one within the ompA coding sequence (CDS) (Figure
2A and B) and another within the ompF 5′ UTR (Figure 2C
and D)––matched cleavage sites we previously identified by
northern (Supplementary Figure S1) and primer extension
analyses (Supplementary Figure S2B and C). Alignment of
theRNA sequences 20 bases up- and downstreamof the 163
cleavage sites revealed a 3-base UUU consensus sequence
from –2 to +1 (where the position of cleavage is immedi-
ately 5′ of the +1 position; Figure 2E).
Surprisingly, six of the 163 cleavage sites were within
tRNA, widely presumed to be refractory to MazF toxin
recognition because of its extensive secondary structure
(1,26,35,56,57). However, MazF-mt9 cleaved these tRNAs
predominantly within their single-stranded loop regions.
In fact, a cleavage site within the UU↓U anticodon of
tRNALys (identical genes lysT, lysW, lysY, lysZ, lysQ and
lysV; Figure 2F–I) was enriched 620-fold relative to the con-
trol, ranking third among all MazF-mt9 target RNAs iden-
tified by MORE RNA-seq. To validate the tRNA cleav-
age identified byMORERNA-seq, we performed northern
analysis of tRNALys upon expression of MazF-mt9 (Fig-
ure 2G) and observed the appearance of an RNA frag-
ment whose size was consistent with cleavage within the
UUU anticodon (Figure 2H and I). In addition, tRNALys
was cleaved between 0 and 15 min after MazF-mt9 induc-
tion (Figure 2G), preceding translation inhibition at 30 min
(Figure 1C and D) and arrest of bacterial growth at 60 min
(Figure 1B). However, cleavage of three mRNAs was not
observed until 60 min (Supplementary Figure S1), the same
time that growth arrest started. Therefore, MORE RNA-
seq and northern analyses led to three important conclu-
sions: (i) that the UUU sequence is essential for MazF-mt9
cleavage in vivo, (ii) that tRNAs represent a new class of tar-
get for this MazF toxin family member and (iii) that tRNA
cleavage––not mRNA cleavage––appears to be the underly-
ing cause of MazF-mt9-triggered inhibition of protein syn-
thesis and bacterial growth.
MazF-mt9 preferentially targets a subset of M. tuberculosis
tRNAs
Having identified cleavage sites of MazF-mt9 in E. coli us-
ing MORE RNA-seq, we then sought to identify RNA tar-
gets in the native context of the M. tuberculosis transcrip-
tome.We adapted our RNA-seq approach to identify cleav-
age sites generated upon incubation ofM. tuberculosis total
RNA with recombinant MazF-mt9. We identified 48 cleav-
age sites that were enriched in the presence of MazF-mt9
(Supplementary Data 1). Alignment of the RNA sequences
20 bases up- and downstream of the 48 enriched sites re-
vealed a very strong 3-base UUU consensus sequence from
–2 to +1 (Figure 3A). This cleavage consensus sequence is in
agreement with that derived fromMORERNA-seq (Figure
2E), but is much stronger, as 90% (43 of 48) of the cleavage
sites are identical to the consensus and 96% (46 of 48)match
at two out of three positions. Taken together, our RNA-seq
data established that the preferred MazF-mt9 recognition
motif is UU↓U. However, this short 3-nt motif alone does
not account for MazF-mt9 target recognition as evidenced
by the relatively few cleavage sites detected. As with E. coli,
the identity of RNAs targeted provided insight into the de-
terminants required for MazF-mt9 cleavage.
Remarkably, tRNAs comprise two of the highest ranking
MazF-mt9-mediated cleavage sites detected by RNA-seq
(Supplementary Data 1). A cleavage site in tRNAPro14 (gene
proT; numbering based on the Genomic tRNA Database
(58); Figure 3B–E) exhibited the overall highest fold in-
crease and was enriched 1,617-fold relative to the control
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Figure 3. MazF-mt9 preferentially targets a subset ofM. tuberculosis tR-
NAs. (A) Sequence logo (75) generated by aligning the RNA sequences
surrounding the 48 cleavage sites identified by applying our RNA-seq
method to M. tuberculosis total RNA incubated with MazF-mt9. (B, F)
Histograms representing the ratio of sequencing reads at each nt position
within tRNAPro14 (B) or tRNALys43 (F) inM. tuberculosis total RNA incu-
bated with (+F9) or without (-F9) MazF-mt9. The cleavage site is labeled
with an asterisk (*). (C, G) Primer extension analysis of M. tuberculosis
tRNAPro14 (C) or tRNALys43 (G) incubated with or without toxin MazF-
mt9 (F9) and antitoxin MazE-mt9 (E9). ‘G, A, T, C,’ sequencing ladder.
The red arrow indicates the position of a cleavage product. (D, H) The
RNA sequences surrounding the cleavage sites (indicated by a black ar-
row) identified by RNA-seq (B, F) and primer extension analysis (C, G),
with flanking position numbers from the corresponding M. tuberculosis
tRNA. (E, I) Secondary structure (above) of M. tuberculosis tRNAPro14
(E) or tRNALys43 (I), showing the location of MazF-mt9 cleavage (inset
below). The sequence of the region of tRNALys43 shown is identical to E.
coli tRNALys in Figure 2I. Labeling of tRNA secondary structures is the
same as in Figure 2.
(Figure 3B). Cleavage of tRNALys43 (gene lysT; Figure 3F–
I) was enriched 511-fold relative to the control (Figure 3F),
and occurred at an analogous position to its highly con-
served tRNALys counterpart cleaved in vivo in E. coli (Fig-
ure 2I).
To validate the tRNA cleavage identified by RNA-seq,
we performed primer extension analysis of tRNAPro14 and
tRNALys43 incubated with MazF-mt9 (Figure 3C and G)
and confirmed that MazF-mt9 cleaved these tRNAs within
the UUU motif (Figure 3D and H), each at the same loca-
tion (Figure 3E and I) as detected by RNA-seq. Addition-
ally, four other tRNAs––tRNALys19, tRNAVal22, tRNALeu13
and tRNAAsn36––were among the 48 targets, although they
were enriched an order of magnitude less than tRNALys43.
Overall, MazF-mt9 cleaved six of the 45M. tuberculosis tR-
NAs, confirming tRNA as a new target for a MazF toxin.
MazF-mt9 cleavage of tRNAPro14, tRNALys and tRNAAsn is
predicted to reduce the abundance of many PE/PPE proteins
and essential components of the translation machinery
Given that MazF-mt9 only cleaves a small subset of
tRNAs––including all isoacceptor tRNAs for tRNALys
(two) and tRNAAsn (one), as well as one of the three isoac-
ceptor tRNAs for proline, tRNAPro14––this toxin might
not inhibit the synthesis of all proteins in M. tuberculosis
equally. Thus, we explored the potential effects of MazF-
mt9 activity on translation by performing a series of statis-
tical analyses on M. tuberculosis CDSs to identify protein-
coding transcripts that contain more or fewer than the ex-
pected number of these proline, lysine or asparagine codons.
Transcripts containing a large number of codons recognized
by tRNAPro14, tRNALys or tRNAAsn should be more sen-
sitive to translation inhibition by MazF-mt9, while tran-
scripts with few or none of these codons should be resistant
to translation inhibition. Antitoxin MazE-mt9 is among
only five CDSs that do not contain any of the codons tar-
geted by MazF-mt9. Curiously, the class of proteins pre-
dicted to be the most susceptible to MazF-mt9 is different
depending on the parameters used to sort the data.
We first analyzed allM. tuberculosis CDSs for the abun-
dance of proline, lysine or asparagine codons. Among the
top 22 proteins predicted to be susceptible to MazF-mt9
based on our statistical analysis described in the Materials
andMethods (Supplementary Table S4), 86% (19 of the top
22) belong to the proline-glutamate (PE)/proline-proline-
glutamate (PPE) family, so named because they contain a
conserved, single PE or PPEmotif at theirN terminus. Like-
wise, of the top 25 CDSs with the highest actual number of
MazF-mt9-targeted codons (Supplementary Table S5), 16
(64%) are members of the PE/PPE protein family. Mem-
bers of this large PE/PPE protein family (comprising nearly
10% of the M. tuberculosis CDS) have intriguing connec-
tions to pathogenesis, virulence, antigenic variation and the
host immune response (59,60). The proposed high sensitiv-
ity of PE/PPE proteins to MazF-mt9 cleavage of tRNAs is
likely due to the overrepresentation of asparagine codons
in (GGAGGN)n or GN-rich amino acid repeats in approx-
imately half of the PE/PPE family members.
In our third analysis, we prioritized the data based on the
abundance of proline, lysine or asparagine codons at the
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beginning of all M. tuberculosis CDSs. We chose the first
30 codons since there is experimental evidence––ribosome
profile experiments (61) and translation efficiency studies
with early rare codons (62–64)––demonstrating that trans-
lation proceeds at a slower rate and has a greater chance
of stalling within the first 25 to 40 codons. Of the top 28
proteins whose synthesis was predicted to be the most sen-
sitive to MazF-mt9 using this analysis, 36% (10 of 28) are
directly involved in translation (ribosomal proteins; Supple-
mentary Table S6). This analysis suggests that by targeting
tRNAPro14, tRNALys and tRNAAsn, MazF-mt9 broadly in-
hibits translation by blocking synthesis of essential compo-
nents of theM. tuberculosis translation machinery.
MazF-mt9 recognizes RNA sequence and structure within the
tRNALys43 anticodon stem-loop
To ascertain which sequence or structural elements in RNA
are required for MazF-mt9 target selection and cleavage,
we first sought to find a minimal tRNA-based MazF-mt9
substrate. We selected the anticodon stem-loop (ASL) of
M. tuberculosis tRNALys43 for three reasons. First, although
MazF-mt9 cleaves each of the two tRNALys isoacceptors
present inM. tuberculosis, only tRNALys43 contains a com-
plete UUU motif. Second, we confirmed MazF-mt9 cleav-
age of M. tuberculosis tRNALys43 upon northern analysis
using an isoacceptor-specific oligonucleotide complemen-
tary to the ASL (Supplementary Figure S5). Third, an E.
coli tRNALys isoacceptor has a high degree of sequence and
structural identity toM. tuberculosis tRNALys43 and is also
cleaved within this conserved UUUmotif in the anticodon,
indicating that this tRNA is cleaved in vitro and in vivo.
We next developed an in vitro cleavage assay to test
whether secondary structure contributes to MazF-mt9
recognition of tRNA. Briefly, short RNA oligonucleotides
were designed that either match the wild-type tRNALys43
ASL or contain mutations that disrupt RNA sequence or
secondary structure as illustrated at the top of Figure 4A
and B. We then incubated each of these 5′-end-radiolabeled
RNAs with or without the MazF-mt9 toxin or MazE-mt9
antitoxin, separated the resulting RNA fragments by gel
electrophoresis and visualized the radiolabeled RNAby au-
toradiography. As a control, we first demonstrated that full-
length tRNALys43 was cleaved byMazF-mt9 in vitro (Figure
4A, lane 3), consistent with our RNA-seq (Figure 3F) and
primer extension (Figure 3G) data. Addition of MazF-mt9
to tRNALys43 produced an RNA fragment≈35 nt in length,
consistent with cleavage at 34UU↓U36 within the anticodon.
This cleavage resulted from MazF-mt9 and not a contami-
nating RNase, since incubation of the MazE-mt9 antitoxin
with MazF-mt9 prior to addition of RNA substrate abol-
ished cleavage (Figure 4A, lane 2).
We then tested whetherMazF-mt9 was also able to cleave
a 15-nt RNA oligonucleotide consisting of the tRNALys43
ASL (Figure 4, lanes 4–6, and Figure 4B, lanes 1–3). As
with the entire tRNALys43, MazF-mt9 produced an RNA
cleavage fragment (Figure 4A, lane 6, and Figure 4B, lane 3)
that was prevented by preincubation with MazE-mt9 (Fig-
ure 4A, lane 5, and Figure 4B, lane 2). The RNA fragment
resulting from MazF-mt9-mediated cleavage was ≈8 nt in
Figure 4. MazF-mt9 requires both sequence and structural determinants
for tRNA cleavage. (A, B) tRNALys43 and mutated ASL derivatives illus-
trated as in Figure 3. RNA incubated with or without MazF-mt9 (F9)
or MazE-mt9 (E9) as indicated. Numbering in RNA oligonucleotides
corresponds to the nt position of anticodon residues in the full-length
tRNALys43. Dark green highlights the anticodon position. Nt identical to
the MazF-mt9 UUUmotif are in red text, while nt mutated from the wild-
type tRNALys43 ASL are in blue text. Yellow arrows indicate cleavage sites.
Black lines connecting complementary nt indicate base-pairing as part of
the anticodon stem. (A) RNA was radiolabeled at the 5′ end prior to ad-
dition of toxin. The red arrows correspond to a ≈35-nt or a ≈8-nt RNA
fragment generated by MazF-mt9 cleavage. Tick marks indicate either a
35-nt DNA oligonucleotide or 10-nt and 5-nt RNA oligonucleotides, each
containing a 5′-end-radiolabel. (B) RNA cleavage was visualized by stain-
ing with SYBR Gold. We empirically determined that a 10-nt but not a
5-nt RNA oligonucleotide can be visualized by SYBR Gold staining and
that RNAoligonucleotides predicted to form a stem stain withmore inten-
sity than linear oligonucleotides. Thus, the≈8-nt RNA fragments expected
in lanes 3 and 6 cannot be seen here, and RNA in lanes 7–9 appears less
intense than RNA in lanes 1, 2, 4 and 5 despite the fact that equal molar
amounts of all oligonucleotides were loaded in all lanes. Tick marks indi-
cate a DNA marker.
length, consistent with cleavage between the residues that
correspond to U35 and U36 within the anticodon.
Having established a minimal RNA substrate for MazF-
mt9 cleavage, we then tested which sequence or structural
elements are required for MazF-mt9 recognition. First, we
replaced the three U nucleotides comprising the anticodon
with A residues (Figure 4A, lanes 7–9), which resulted in
no detectable MazF-mt9-mediated cleavage (lane 9). This
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result indicates that the UUU motif is required for MazF-
mt9 recognition. Second, we shifted the UUUmotif from a
position in the anticodon loop directly opposite the stem
to the side of the loop immediately adjacent to the stem
(Figure 4A, lanes 10–12). This also resulted in no detectable
cleavage (Figure 4A, lane 12), suggesting that theUUUmo-
tif must be positioned at a specific location within a loop.
Third, we mutated the 5′ half of the stem to be identical
to the 3′ half instead of complementary to it, thereby de-
stroying the stem and forming a linear RNA with a UUU
motif (Figure 4A, lanes 13–15). Despite the presence of the
UUUmotif in this linear oligonucleotide, this RNAwas not
cleaved (Figure 4A, lane 15), suggesting that the stem is nec-
essary forMazF-mt9 recognition. Finally, anRNAoligonu-
cleotide lacking both the stem and the UUU motif was not
cleaved (Figure 4A, lane 18), which was expected by the lack
of cleavage when either the sequence or structural determi-
nant alone was removed (Figure 4A, lanes 9 and 15).
To confirm whether MazF-mt9 requires the stem in the
ASL to recognize and cleave tRNALys43, we reconstituted
the stem that we disrupted in Figure 4A, lanes 13–15. We
mutated the 3′ half of the stem to be complementary to the
prior mutations in the 5′ half of the stem, thereby restor-
ing the structure but not the sequence of the stem from the
wild-type tRNALys43 ASL (Figure 4B, lanes 4–6). MazF-
mt9 cleaved this RNA oligonucleotide alone (Figure 4B,
lane 6) but not when preincubated withMazE-mt9 (lane 5),
confirming that the stem is necessary for MazF-mt9 recog-
nition. To rule out the possibility that the sequence in the
5′ half of the stem is recognized by MazF-mt9, we mutated
the 3′ half of the stem to form a linear oligonucleotide with
a UUUmotif in the anticodon (Figure 4B, lanes 7–9). This
RNA was not cleaved (Figure 4B, lane 9), just as with the
linear oligonucleotide mutated at the 5′ half of the stem
(Figure 4A, lane 15), confirming that the structure and not
the sequence of the stem is crucial. Thus, the results of our
in vitro cleavage assays establish that MazF-mt9 recognizes
its RNA targets on the basis of both the presence of a UUU
sequence and its structural context.
DISCUSSION
MazF-mt9 exhibits two properties distinct from all other
MazF family members. First, it appears to preferentially
cleave tRNA within single-stranded loops, and second, it
exhibits exquisite selectivity for this novel target by requir-
ing both sequence and structural determinants. By com-
parison, recognition and cleavage by all other character-
ized MazF toxins require only (i) the presence of the
cleavage recognition motif for to that particular toxin, (ii)
that this motif resides within a single-stranded region of
RNA and (iii) that the motif is free of interacting pro-
teins or a tertiary fold that can sterically block the toxin.
In addition, our findings also contradict earlier assump-
tions that all MazF toxins only cleave mRNAs and can-
not cleave tRNA (1,26,35,56,57) due to its extensive double-
stranded regions and conserved tertiary fold. Finally, our
results also expose unforeseen functional parallels between
MazF-mt9 and some VapC toxins that also primarily tar-
get tRNA (47,65). Relationships between toxin families
have been forged based on compelling sequence and struc-
tural similarities (5,66–68). However, unlike the clear rela-
tionships within the MazF toxin family (including ChpBK
and PemK/Kid) and the RelE family (including HigB and
YoeB), the MazF and VapC families have been kept func-
tionally distinct because they do not exhibit significant se-
quence or structural similarities. However, our results reveal
that protein sequence and structure alone cannot always
predict functional relationships between individual toxins.
Collectively, our data indicate that mRNA is not a pre-
ferred target of MazF-mt9. We only observed 23 CDSs
cleaved by MazF-mt9 in our RNA-seq results, a small frac-
tion of the 3803 M. tuberculosis protein-coding genes. By
comparison, 99% of E. coli CDSs are susceptible to target-
ing by the ACA-cleaving MazF. This dearth of sites within
CDSs in ourRNA-seq data set is consistent with the relative
lack of MazF-mt9-mediated cleavage detected by northern
and primer extension analyses despite interrogation of a
large number of mRNA substrates (Supplementary Figures
S1–S3 and Table S3). In fact, MazF-mt9 cleaved UUUmo-
tifs within these mRNA transcripts at a rate of only 2%,
suggesting that most mRNAs do not contain the required
structural determinant(s) for MazF-mt9 cleavage. In con-
trast, the relatively few mRNAs that are cleaved appear to
be targeted because they possess the sequence and struc-
ture required by MazF-mt9. For example, when we pre-
dicted the secondary structure of the top 10 MORE RNA-
seq cleavage sites in mRNA using RNAstructure (49), all
10 mRNA structures cleaved byMazF-mt9 resemble tRNA
arms (Supplementary Figure S6), with the cleavage sites lo-
cated in a short (≤11-nt) single-stranded loop directly op-
posite a stem as with the MazF-mt9-mediated tRNA cleav-
age sites we observed (Figures 2I and 3E and I, Figure 4,
and Supplementary Figure S5). Likewise, nine of the top
10 mRNAs in M. tuberculosis cleaved by MazF-mt9 and
detected using our RNA-seq approach resemble an arm
of tRNA (Supplementary Figure S7). Finally, MazF-mt9
cleaved tRNALys (Figure 2G) at a faster rate than three
mRNAs (Supplementary Figure S1), suggesting that tRNA
cleavage and not mRNA cleavage was the underlying cause
of MazF-mt9-mediated translation inhibition and subse-
quent growth arrest. There was a sharp decline in tRNALys
between 0 and 15 min after induction of MazF-mt9 (Fig-
ure 2G) that preceded translation inhibition around 30 min
(Figure 1C and D) and growth inhibition at 60 min (Figure
1B). However, cleavage of the three mRNAs was not de-
tected until 60 min (Supplementary Figure S1), the same
time as commencement of growth inhibition, suggesting
that at least these three mRNAs are secondary targets of
MazF-mt9 when compared with tRNALys.
In terms of sequence requirements, MazF-mt9 prefers to
cleave RNA within a UU↓U motif. Yet while the UUU
sequence is necessary for cleavage, it is not sufficient. The
UUU must be in the preferred structural context. Our ini-
tial experiments revealed that MazF-mt9 only cleaved 2%
(6 of 251) of the UUU motifs in all the RNA substrates
we tested using primer extension analysis of abundant E.
colimRNAs and MS2 RNA (Supplementary Table S3). By
contrast, other MazF toxins typically cut at all or nearly
all cleavage sequences. For example, MazF-mt6 cleaves all
UUCCU cleavage motifs present in the three E. coli mR-
NAs (ompA, ompF and tufA) (32). Also, the MazF-mt9
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recognition motif UUU is represented 18,701 times in the
M. tuberculosis transcriptome (either as a solitary UUU se-
quence or as a 4- to 8-nt string of U residues), yet we de-
tected a very limited number of individual RNAs preferen-
tially cut by MazF-mt9 in our RNA-seq analysis (i.e. 48, or
0.3% of the UUU sequences in the transcriptome). Then,
once we identified certain tRNAs as a primary targets we
noted that several UUU motifs in single-stranded regions
of these tRNAs were not cleaved, suggesting MazF-mt9
also requires another determinant for target recognition.
We also determined that the MazF-mt9-mediated cleavage
sites in mRNA (Supplementary Figures S5 and S6) were
largely in the same context as the cleavage sites within tR-
NAs (i.e. in a stem directly opposite a loop), while the ma-
jority of uncut UUU motifs in mRNAs were not. Finally,
mutagenesis of the tRNALys43 ASL to create variants in the
sequence or position of theUUUmotif or in the structure of
the stem revealed that cleavage by MazF-mt9 requires that
the UUU be positioned in the proper structural context.
Interestingly, at least two major positions in the tRNA
architecture were cleaved, both occurring in the loop por-
tion of a stem-loop. MazF-mt9 cleaved tRNAPro14 within
a UU↓U sequence in the D-loop (Figure 3E) and cleaved
tRNALys43 within the UU↓U anticodon in the ASL (Fig-
ure 3I). Importantly,M. tuberculosis tRNALys43 (Figure 3I)
and E. coli tRNALys (Figure 2I) are identical in nucleotide
length and structure, and the anticodon loop of tRNALys43
is 100% identical to its counterpart in E. coli tRNALys,
which was also cleaved byMazF-mt9 in vivo (Figure 2F and
G). Therefore, tRNALys isoacceptors fromboth bacteria are
cleaved at the same position within the UU↓U anticodon
(Figures 2I and 3I). However, no counterpart of MazF-mt9
substrate tRNAPro14 from M. tuberculosis is cleaved in E.
coli, most likely because tRNAPro14 is the only tRNA of all
45 M. tuberculosis tRNAs and all 88 E. coli tRNAs that
contains a complete UUU motif in the D-loop. The abil-
ity of MazF-mt9 to cleave tRNA at these two positions
means this toxin not only generates tRNA halves but also
smaller tRNA-derived fragments, which together comprise
an intriguing class of small RNAs recently found in RNA-
seq data sets from all domains of life and whose functions
are just beginning to be determined experimentally (69,70).
Overall, MazF-mt9 cleaved the majority of its tRNA tar-
gets within the anticodon arm, similar to bacterial tRNases
including colicins D and E5 (71), anticodon nuclease PrrC,
which exclusively targets E. coli tRNALys (72), and three re-
cently characterized VapC toxins (47,65).
Cleavage of tRNA is presumably sufficient to impair its
function as a translation adaptor molecule and inhibit pro-
tein synthesis. Therefore, we performed statistical analyses
to identifyM. tuberculosis proteins whose translation is pre-
dicted to be impaired upon reduction of the major tRNAs
cleaved by MazF-mt9 (Supplementary Tables S4–S6). De-
pending on the parameters selected for sorting, we identified
two predominant classes of susceptible proteins: PE/PPE
proteins or ribosomal proteins. It is not clear which of these
predicted scenarios most closely reflects in vivo events. If
the goal is to arrest bacterial growth or initiate cell death,
however, it is unclear why these toxins and other bacterial
tRNases only target specific, and sometimes low-usage, tR-
NAs. As such, it is intriguing to speculate that MazF-mt9-
generated tRNA halves or fragments may have additional
functional roles or be able to inhibit translation by interact-
ing directly with the translation machinery as in eukaryotes
or archaea (69,70).
In addition to having a preference for cleaving tRNA,
MazF-mt9 also targeted other M. tuberculosis noncoding
regions. The 12 cleavage sites in our RNA-seq data set that
mapped to 5′ untranslated regions (5′ UTRs) or intergenic
regions (IGRs) should affect translation of multiple pro-
teins, as all the downstream CDSs in a polycistronic operon
normally depend on translation of the upstream genes. Four
of the cleavage sites within IGRs are upstream of the three
M. tuberculosis rRNA genes, which are located in a sin-
gle operon. Since maturation of rRNAs requires distinct
secondary structures in the precursor transcript to be rec-
ognized in a series of stepwise cleavage events by several
endoribonucleases, it is expected that MazF-mt9-mediated
cleavage at any of these four IGRs would inhibit rRNA
maturation and ribosome biogenesis. These predictions are
complementary to the results of our statistical analyses in
Supplementary Table S6, where ribosomal proteins com-
prise >35% of the top 28 M. tuberculosis proteins whose
synthesis are predicted to be lessened as a result of the
downstream effects of MazF-mt9 cleavage of its tRNA tar-
gets.
Our RNA-seq data also showed that M. tuberculosis
rRNAswere cleaved at six different locations byMazF-mt9,
including a single site in 16S rRNA and five others in 23S
rRNA (Supplementary Data 1). However, these sites ap-
pear to be an artifact of cleaving M. tuberculosis rRNA in
the absence of ribosomal proteins, because the correspond-
ing rRNA sites were not cleaved when MazF-mt9 was ex-
pressed inE. coli, despite the overall high degree of sequence
and structural conservation between rRNAs from these two
bacteria. It is likely that these putative rRNA cleavage sites,
which arose from an in vitro cleavage assay usingM. tuber-
culosis total RNA, would normally be protected by riboso-
mal proteins under physiological conditions. This argument
is strengthened by the fact that specific ribosomal proteins
bind immediately adjacent to or within all six of the po-
tential cleavage sites inM. tuberculosis rRNA (73,74). Con-
versely, other RNA species from E. coli andM. tuberculosis
were cleaved byMazF-mt9 at identical sites, such as several
UUUorUUmotifs conserved between tRNAs in both bac-
teria. This suggests that although the putative rRNA cleav-
age sites inM. tuberculosis would not be cleaved by MazF-
mt9 in the context of the native ribosome, most otherM. tu-
berculosis target RNAs (Supplementary Data 1) likely rep-
resent bona fide MazF-mt9 targets since none of them are
known to form stable interactions with protein complexes.
In total, our data suggest thatMazF-mt9-mediated cleav-
age of specific tRNAs controlsM. tuberculosis growth by di-
rectly and indirectly targeting essential components of the
translation machinery. This mechanism has intriguing par-
allels to the eukaryotic stress response, where the accumu-
lation of tRNA halves and other species analogous to those
created by MazF-mt9 are implicated in regulation of not
only translation, but also apoptosis and RNA interference
(69,70). Since MazF-mt9 cleaves all lysine tRNAs, the only
asparagine tRNA and the second most abundant tRNAPro
(codon usage 29%) in M. tuberculosis, MazF-mt9 is pre-
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dicted to inhibit or reduce the rate of protein synthesis from
any transcript coding for an abundance of these three amino
acids. One of the three computational approaches we per-
formed to predict proteins sensitive toMazF-mt9 revealed a
large percentage involved in translation (SupplementaryTa-
ble S6). In addition, MazF-mt9 cleavage within the rRNA
precursor transcript at regions upstream of all three rRNAs
likely inhibits their maturation and assembly into the ri-
bosome, which would also negatively impact translation.
This targeting of a handful of tRNAs, along with cleavage
of other RNAs, suggests that MazF-mt9 launches a multi-
pronged attack on the translation machinery to downregu-
late protein synthesis as a tool to regulate cell growth.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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